Tracker Biobank, 145 Studley Road, Melbourne (2026)

21/01/2026

🎉 First Screening-Detected Case Collected 🎉

Today we reached a landmark moment for TRACKER, collecting our first lung cancer samples from a patient identified through Australia’s new national lung cancer screening program (launched July 2025).

This is a particularly important moment because it marks the beginning of TRACKER being able to facilitate research focused on cancer detected through screening. This is critical for understanding how lung cancer develops and how we can improve early diagnosis and treatment.🔬

A heartfelt thank you to the patient for their generosity in taking part, your contribution is helping build the foundation for future breakthroughs. 🙏

Special thanks also to the team who assisted with collection and processing:
- Dr Senthuran Shivakumar (Respiratory & Sleep Physician)
- Dr Celia Lanteri (Respiratory & Sleep Physician)
- Dr Natalia Vukelic (Project Manager)
- Nhi Huynh (Research Assistant)

This milestone showcases how screening is not only saving lives today, but also powering the research that will save lives tomorrow. 💛
___

Austin Health Australian Government Department of Health, Disability and Ageing
Cancer Australia

06/01/2026

Grant Success for Lung Cancer! 🎉

We’re proud to share that TRACKER Co-Lead A/Prof Sagun Parakh has been awarded a 2026 grant from the Austin Medical Research Foundation (AMRF) for the project “Personalising Treatment for Early-Stage Lung Cancer.” 🔬

AMRF supports medical research across the Austin Precinct, and we’re very grateful to Austin Health for their ongoing support of TRACKER. From bronchoscopy suite staff, oncologists, and anaesthetists, to day oncology nurses - their combined efforts make this research possible.

This project will help deliver more precise, patient-centred care, and we can’t wait to see its impact in the clinic. 💫

Congratulations to Sagun and the team on this important achievement! 👏

___

31/12/2025

✨ Stepping into 2026 with purpose, pride, and possibility ✨

As we turn the page on 2025, we’re incredibly proud of the progress we’ve made and the momentum we’ve built together. Every connection formed, every sample contributed, and every insight gained brings us closer to creating meaningful impact for people affected by lung cancer. 🙌

Looking ahead, 2026 holds great promise. We’re excited for new research discoveries, hopeful grant successes, and continued collaboration that strengthens both our work and our community. Above all, we remain committed to making a meaningful difference in the challenges lung cancer patients face — while also addressing inequities in participation in biobanking and research among Culturally and Linguistically Diverse communities and Aboriginal and Torres Strait Islander peoples.

We wish everyone a year filled with health, happiness, joy, and connection, and we’re deeply grateful to have you alongside us on this journey. We can’t wait to see (and celebrate!) the impact we’ll create together. 🎉

Here’s to a year of purpose, progress, and positive change 💕

___

24/12/2025

🎄 Merry TRACKER Christmas 🎄

As 2025 draws to a close, we’re reflecting on a year defined by momentum, collaboration, and belief in what’s possible. Together, we more than doubled patient recruitment, expanded TRACKER into five states, and welcomed seven hospitals and nine research institutes into our growing national network. What started as an idea continues to evolve into something truly powerful. 🙌

This year brought moments worth celebrating:
✨ Dr Sarah Yeo and Dr Senthuran Shivakumar published their first manuscripts as TRACKER PhD students
✨ Grant success for Dr Sagun Parakh, Co-Lead of TRACKER
✨ Dr Tracy Leong, Co-Lead of TRACKER, recognised with the Lung Foundation Australia Women of Influence Award
✨ And our Consumer Chair, Lisa Briggs, honoured with two national awards for her outstanding leadership in lived experience

Beyond the milestones, TRACKER’s mission and vision was shared across local and international conferences, opening doors to new partnerships, new conversations, and a shared commitment to research that truly matters.

This Christmas, we come together as a team - to celebrate, reflect, and look ahead. Our community continues to grow across disciplines and across states, united by one purpose: to improve both the length and quality of life for people living with lung cancer.

We also know this season can be a difficult one. To those facing diagnosis or treatment, or remembering someone dearly missed - our thoughts are with you. You are at the heart of why TRACKER exists ❤️

Thank you to everyone who has supported, believed in, and contributed to TRACKER this year. The foundations are strong, the momentum is real, and we’re excited for what’s ahead!

Here’s to continuing this journey, together.🤝

🔗 Learn more: www.trackerbiobank.com

____

24/12/2025

🎄✨ A very special Christmas Eve milestone: 200 patients. One extraordinary achievement.

As we celebrate the festive season, TRACKER is proud to mark 200 patients recruited nationwide across NSW, VIC, SA, QLD and WA. Together, you’re helping build a national resource accelerating research into the world’s deadliest cancer: lung cancer.

This milestone reflects the outstanding collaboration and commitment of our hospital partners:
🏥 Austin Health (VIC)
🏥 The Royal Melbourne Hospital (VIC)
🏥 Macquarie University Hospital (NSW)
🏥 St Vincent's Hospital, Sydney (NSW)
🏥 Royal Adelaide Hospital (SA)
🏥 Royal Brisbane and Womens Hospital (QLD)
🏥 Sir Charles Gairdner Hospital (WA)

Most importantly, we extend our sincere gratitude to the 200 patients who have generously contributed their samples and data. Your courage and willingness to participate are at the heart of TRACKER and will help shape the future of lung cancer care. 🙏💫

We look forward to building on this momentum together. 🚀

—

Metro North Health North Metropolitan Health Service

22/12/2025

🗣️ Dr Senthuran Shivakumar presents in Adelaide!

We’re excited to share that Dr Shivakumar, PhD student with the TRACKER Biobank, presented at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) & Hypertension Australia Joint Scientific Meeting, held 9–12 December 2025 at the Adelaide Convention Centre.

Dr Shivakumar shared his research on biomarkers - early warning signs in lung cancer - and how they could help improve patient care. His talk sparked engaging discussions, highlighted the TRACKER Biobank, and helped him make valuable connections with researchers across the region. 🤝

A huge thank you to ASCEPT, Hypertension Australia, and the organisers for hosting such a fantastic, well-run meeting.

Congratulations, Dr Shivakumar, on a rewarding and impactful experience! 💫

______

14/12/2025

🌞 Welcome, Queensland! 🌞

We’re proud to welcome The Royal Brisbane and Women’s Hospital (RBWH) and The University of Queensland (UQ) to TRACKER — bringing world-class clinical and research expertise from the heart of Queensland’s healthcare community.

Marking their official entry into Australia’s national lung cancer biobank, the team collected their first patient samples for TRACKER on November 20 🫁

Renowned for excellence in multidisciplinary collaboration and translational research, RBWH and UQ unite clinical expertise with discovery science - accelerating progress toward more effective, tolerable, and accessible lung cancer care for patients across Australia. 💙

The RBWH Team
👨‍⚕️ A/Prof David Fielding – Respiratory Physician & Site PI
👨‍⚕️ A/Prof Brett Hughes – Medical Oncologist
👩‍⚕️ Dr Zarnie Lwin – Medical Oncologist
📋 Kimberley Ryan – Site Coordinator
📋 Haibing Wu – Site Coordinator

The UQ Centre for Clinical Research Team
🔬 Prof Simpson – Laboratory Head & Site PI
🧬 Kate Fitzgerald – Research Assistant
🧬 Dr Andrew Dalley – Postdoctoral Research Scientist
🧬 Dr Kate Beecher Matthews – Postdoctoral Research Fellow

Get ready for recruitment numbers to ramp up! Queensland’s inclusion in TRACKER strengthens Australia’s collective capacity to drive discoveries that will transform lung cancer care and outcomes.

Metro North Health The University of Queensland

Learn more: https://www.trackerbiobank.com/post/queensland-joins-tracker-expanding-australia-s-lung-cancer-research-capacity

–––

10/12/2025

🎉 Western Australia Joins TRACKER! 🎉

The Sir Charles Gairdner Hospital (SCGH) and the Institute for Respiratory Health (IRH), together with Murdoch University and The University of Western Australia (UWA), have officially joined the national TRACKER network, uniting clinicians and researchers to better understand and treat lung cancer.

Today, the WA team reached a major milestone, collecting their first lung cancer patient sample for the biobank 🫁

This achievement coincides with the recent introduction of robotic bronchoscopy at SCGH - making it one of only a few hospitals in Australia with this advanced technology.

The robot allows clinicians to access small, hard-to-reach areas of the lung, improving tissue yield and enabling TRACKER to collect samples from earlier-stage cancers, strengthening research and patient outcomes nationwide.

The WA Team
👨‍⚕️ Dr Dhaval Thakkar – Respiratory Physician & Site PI, SCGH
👨‍⚕️ Dr Xinxin Hu – Respiratory Physician & Associate Investigator
📋 Nicola Clarkson– Site Coordinator, SCGH
📋 Katie Straker – Site Coordinator, SCGH
👩‍🔬 A/Prof Cecilia Prele – Laboratory Head & Site PI, IRH and Murdoch University
🧬 Jorjina Plester – Research Assistant, IRH

Together, we are advancing earlier detection, more effective treatments, and better outcomes for Australians living with lung cancer. 💙

Institute for Respiratory Health North Metropolitan Health Service The University of Western Australia Murdoch University

Learn more: https://lnkd.in/gstBq_GZ

–––

27/11/2025

🎉 Huge congratulations to Dr Senthuran Shivakumar for being awarded Best Presentation at the TSANZ - Thoracic Society of Australia and New Zealand VIC Branch ASM last week! 🎉

Dr Shivakumar presented groundbreaking early TRACKER findings, shining a spotlight on the role of the lung microbiome in checkpoint inhibitor pneumonitis - a serious side effect that can affect patients undergoing immunotherapy for lung cancer. His work is helping to unravel why some patients develop this condition and how we can improve early detection and treatment in the future.

This recognition is a testament to the incredible research happening at TRACKER and the dedication of our scientists to improving the lives of people living with lung cancer. We are so proud to see Dr Shivakumar’s work being celebrated and shared with the wider medical community! 🌟

👏 Keep inspiring us, Dr Shivakumar - your research is making a real difference! 💙

_____

26/11/2025

🌍 Climate & Lung Cancer: A Growing Intersection We Can’t Ignore

Climate change isn’t just warming the planet — it’s putting our lungs under increasing pressure. Rising air pollution, more frequent bushfire smoke, and hotter temperatures are all contributing to a global rise in respiratory illnesses, including lung cancer.

At TRACKER Biobank, we’re committed to advancing early detection and giving communities the insights they need to protect their health. Here’s why environmental change matters for your lungs:

🔎 Did you know?
• Fine particulate pollution (PM2.5) is now one of the fastest-growing global risk factors for lung cancer
• Bushfire smoke carries carcinogenic toxins that can travel thousands of kilometres
• Rural and remote communities across Australia, already facing health inequities, are disproportionately affected

💡 Climate change is a health issue.
And awareness is one of our strongest tools.

Let’s work together to push for cleaner air, support early detection, and protect our communities. 🙌

One simple daily habit: Check the Air Quality Index (AQI).
🔵🟢 Safe to enjoy the outdoors
🟡🟠 Be cautious, reduce strenuous activity
🟣🔴 Limit or avoid outdoor time

🔗 Check your local air quality in Victoria here:
https://www.epa.vic.gov.au/check-air-and-water-quality?type=airForecast

For all other states, visit:
https://www.dcceew.gov.au/environment/protection/air-quality

Your lungs are precious, protect them daily 💙

—

Environment Protection Authority Victoria

24/11/2025

We’re excited to share that TRACKER Biobank contributed to a major new CSIRO report showing that better coordination of Australia’s biobanks could deliver up to $39 million in annual benefits — helping researchers make breakthroughs faster and improving health outcomes nationwide 🧬💡

Australia has more than 200 biobanks and 4 million biospecimens, yet many work independently. A nationally coordinated platform would streamline access, reduce duplication, and strengthen lifesaving medical research ⚡🏥

🌟 TRACKER Biobank is proud to be a working example of this coordinated future.

Our patient-centred, longitudinal, and data-rich lung cancer biobank shows how strong governance, collaboration, and standardisation can future-proof biospecimens and give researchers access to high-quality samples linked to rich clinical and genomic data 🧪📊

This is what’s possible when data, partnerships, and patient focus come together — exactly the model the CSIRO report recommends for a connected national biobanking ecosystem 🙌

🔗 Learn more in the full CSIRO report:
https://www.csiro.au/en/news/all/news/2025/september/unlocking-the-potential-of-australias-biobanking-capabilities

Share your thoughts below!
____

20/11/2025

🫁 What is Checkpoint Inhibitor Pneumonitis (CIP)?

CIP is a serious side effect of some immunotherapy treatments used for lung cancer. These therapies help the immune system recognise and respond to cancer — but sometimes the immune system can become overactive, leading to significant inflammation in the lungs.

Understanding how CIP is recognised and managed is essential for improving patient care across Australia.

🧪 What we're doing
Our TRACKER Biobank research team is running a national study to better understand how doctors across the country manage CIP in real-world clinical practice.

👩‍⚕️👨‍⚕️ Why this matters
CIP can be complex, and approaches can vary between hospitals. By gathering insights from clinicians, researchers can build a clearer picture of current care, helping guide future improvements in treatment, guidelines, and patient outcomes.

This project is led by our PhD candidate and Respiratory Physician, Dr Senthuran Shivakumar.

📚 Research like this brings us one step closer to safer, more effective care for people living with lung cancer.

___

Uni Melbourne Olivia Newton-John Cancer Research Institute Thoracic Oncology Group of Australasia Ltd TSANZ - Thoracic Society of Australia and New Zealand

Tracker Biobank

21/01/2026

06/01/2026

31/12/2025

24/12/2025

24/12/2025

22/12/2025

14/12/2025

10/12/2025

27/11/2025

26/11/2025

24/11/2025

20/11/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category